Ventripoint Diagnostics Stock Price To Earning
| VPTDF Stock | USD 0.10 0.01 9.09% |
VentriPoint Diagnostics fundamentals help investors to digest information that contributes to VentriPoint Diagnostics' financial success or failures. It also enables traders to predict the movement of VentriPoint OTC Stock. The fundamental analysis module provides a way to measure VentriPoint Diagnostics' intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to VentriPoint Diagnostics otc stock.
VentriPoint |
VentriPoint Diagnostics OTC Stock Price To Earning Analysis
VentriPoint Diagnostics' Price to Earnings ratio is typically used for current valuation of a company and is one of the most popular ratios that investors monitor daily. Holding a low PE stock is less risky because when a company's profitability falls, it is likely that earnings will also go down as well. In other words, if you start from a lower position, your downside risk is limited. There are also some investors who believe that low Price to Earnings ratio reflects the low pricing because a given company is in trouble. On the other hand, a higher PE ratio means that investors are paying more for each unit of profit.
Current VentriPoint Diagnostics Price To Earning | 68.00 X |
Most of VentriPoint Diagnostics' fundamental indicators, such as Price To Earning, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, VentriPoint Diagnostics is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Generally speaking, the Price to Earnings ratio gives investors an idea of what the market is willing to pay for the company's current earnings.
| Competition |
Based on the latest financial disclosure, VentriPoint Diagnostics has a Price To Earning of 68 times. This is 163.16% higher than that of the Healthcare sector and 2.68% lower than that of the Medical Devices industry. The price to earning for all United States stocks is 136.77% lower than that of the firm.
Did you try this?
Run Portfolio Suggestion Now
Portfolio SuggestionGet suggestions outside of your existing asset allocation including your own model portfolios |
| All Next | Launch Module |
VentriPoint Fundamentals
| Return On Equity | -1.35 | |||
| Return On Asset | -0.64 | |||
| Operating Margin | (124.50) % | |||
| Current Valuation | 28.27 M | |||
| Shares Outstanding | 156.51 M | |||
| Shares Owned By Insiders | 1.75 % | |||
| Price To Earning | 68.00 X | |||
| Price To Book | 8.27 X | |||
| Price To Sales | 897.04 X | |||
| Gross Profit | (6.27 K) | |||
| EBITDA | (3.82 M) | |||
| Net Income | (3.88 M) | |||
| Cash And Equivalents | 7.29 M | |||
| Cash Per Share | 0.05 X | |||
| Total Debt | 125.38 K | |||
| Debt To Equity | 0.02 % | |||
| Current Ratio | 6.74 X | |||
| Book Value Per Share | 0.03 X | |||
| Cash Flow From Operations | (3.15 M) | |||
| Earnings Per Share | (0.02) X | |||
| Number Of Employees | 17 | |||
| Beta | 0.28 | |||
| Market Capitalization | 32.09 M | |||
| Total Asset | 9.54 M | |||
| Retained Earnings | (20.43 M) | |||
| Working Capital | (1.99 M) | |||
| Current Asset | 1.07 M | |||
| Current Liabilities | 3.05 M | |||
| Net Asset | 9.54 M |
About VentriPoint Diagnostics Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze VentriPoint Diagnostics's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of VentriPoint Diagnostics using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of VentriPoint Diagnostics based on its fundamental data. In general, a quantitative approach, as applied to this otc stock, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Currently Active Assets on Macroaxis
Other Information on Investing in VentriPoint OTC Stock
VentriPoint Diagnostics financial ratios help investors to determine whether VentriPoint OTC Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in VentriPoint with respect to the benefits of owning VentriPoint Diagnostics security.